Clinical Trial Update: Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing Baracle Tab. and Baraclude Tab. for HBeAg-positive chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baracle Tab.
• Baraclude Tab. (entecavir)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: HBeAg-Positive Chronic Hepatitis B | Phase 4 | Status: COMPLETED